American business magazine Forbes has added three Bangladeshi companies to its “Asia’s 200 Best Under A Billion list”.
The list highlights 200 Asia-Pacific public companies with sales under $1 billion US Dollars (USD). Forbes claims the companies added to the list have” track records of exceptional corporate performance” and “scored above their peers in a composite ranking that includes sales and profit growth, low debt levels and robust governance”
![](https://shomporko.ca/english/wp-content/uploads/2020/09/Omar.jpg)
Of the three, the company to post the biggest figures was Square Pharmaceuticals. The list gives the pharmaceutical company a market value of 1,716 million USD, with a sales and net income of 512 and 150 million respectively. Followed closely by Renata pharmaceutical, which the list attributes a market value of 1,071 million, sales 512 million, and a net income of 45 million US Dollars.
Last one on the list, Fortune Shoes reported a market value of 28 million, with sales and figure of 18 million and a net income of 3 million.
Photo credit: Forbes
News source: The Daily Star